Tests home visits to help manage high blood pressure and type 2 diabetes
Tests home visits against clinic visits for adults with high blood pressure or diabetes.
Key facts
- Who runs it
- University of Texas Southwestern Medical Center
- Where
- Dallas, United StatesSee the site
- Trial code
- Registry title
- Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 27 Jul 2022
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Home visit
- Record updated
- 10 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 60 who speak English or Spanish and have high blood pressure or high blood sugar. It tests home visits against usual clinic visits.
- Age
- 18 to 60 years
- Sex
- All sexes can join.
- Disease stage
- High blood pressure (HTN) or blood pressure above 140/90 in the last 3 months, or hemoglobin A1C above 8 in the last 6 months, based on the medical record. Conditions listed: hypertension and type 2 diabetes.
- Earlier treatment
- People currently taking oral steroids cannot join.
- Biomarker or test result
- Blood pressure above 140/90 in the last 3 months, or hemoglobin A1C above 8 in the last 6 months.
Main reasons for not taking part
- Current oral steroid use
- History of solid organ transplant
- Speaking a language other than English or Spanish
- Being pregnant
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Adult patients ages 18-60
- Spanish or English speaking
- Diagnosis of HTN or BP >140/90 in last 3 months (based on medical record)
- Hemoglobin A1C>8 in last 6 months (based on medical record)
- Not pregnant
Who cannot take part
- Current oral steroid use
- History of solid organ transplant
- Language other than English or Spanish
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Where in United States
- UT Southwestern Medical CenterDallas, United StatesContact: Nora Gimpel, MDTaking people
About the trial
What the trial wants to find out
The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.
The 2 groups in the trial
- Home VisitTreatment being tested
Participants will receive home visit During the course of the first home visit, patients will receive routine care for diabetes and hypertension management (outcome variables are listed below) and data will be recorded in the EHR for primary outcomes. The resident physician will also assist the patient in completing enrollment in MyChart (if interested), utilizing either the resident's computer or smartphone and an internet hotspot. MyChart is a patient health platform that allows patients to contact their healthcare doctors, log health reminders, see test results, and a list of medications. The resident physician will also review a social determinants of health (SDH) screener (included in the EHR). The research faculty (licensed medical clinician) will collect blood pressure readings during this visit.
- Standard of careNo study treatment, for comparison
Participants will receive a standard of care
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
- Plain-language title
- Tests home visits to help manage high blood pressure and type 2 diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05168605, who can take part
- Record updated
- 10 February 2026